Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 208
- Q4 2025, +21 vs. previous quarter
- 13F value
- $1.60B
- Reported value at the end of Q4 2025
- Superinvestors holding
- 0
- At the end of Q4 2025
Superinvestors holding AVDL, Q4 2025
No superinvestor reported holding AVDL at the end of Q4 2025.
Latest insider trades
Open-market purchases and sales by Avadel Pharmaceuticals PLC insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing)5:18 PM ET | Feb 13 | 5 days | Weiss Asset Management LP and 1 otherOther: Former 10% Owner | SSale | −11.1M | $21.00 | −$233.4M | −100.0%0 after | |
| Jan 22, 2025 (view filing) | Jan 21 | 1 day | Palczuk LindaDirector | PPurchase | +5.00K | $7.93 | +$39.6K | +7.9%67.9K after | |
| Jan 14, 2025 (view filing) | Jan 13 | 1 day | Thornton Peter J.Director | PPurchase | +10.0K | $8.05 | +$80.5K | +10.6%104.1K after | |
| Jan 14, 2025 (view filing) | Jan 13 | 1 day | Ende Eric JDirector | PPurchase | +30.0K | $7.84 | +$235.2K | +16.8%208.9K after | |
| Dec 16, 2024 (view filing) | Dec 13 | 3 days | McHugh Thomas SChief Financial Officer | PPurchase | +2.30K | $10.44 | +$24.0K | +2.7%87.8K after | |
| Dec 12, 2024 (view filing) | Dec 11 | 1 day | McHugh Thomas SChief Financial Officer | PPurchase | +5.00K | $10.49 | +$52.5K | +6.2%85.5K after | |
| Dec 10, 2024 (view filing) | Dec 6-9 | 4 days | Divis Gregory JChief Executive Officer | PPurchase | +10.0K | $9.97 | +$99.7K | New position10.0K after | 2 lots |
| Dec 10, 2024 (view filing) | Dec 10 | Same day | Glass Geoffrey MichaelDirector | PPurchase | +20.3K | $9.84 | +$199.6K | +36.5%75.9K after | 2 lots |
| Dec 10, 2024 (view filing) | Dec 6 | 4 days | Palczuk LindaDirector | PPurchase | +3.00K | $10.19 | +$30.6K | +4.7%66.4K after | |
| Jan 16, 2024 (view filing) | Jan 16 | Same day | McHugh Thomas SChief Financial Officer | PPurchaseADSs | +2.00K | $14.50 | +$29.0K | +2.5%80.5K after |
Top 10 13F holders, Q4 2025
The largest institutional positions in Avadel Pharmaceuticals PLC at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,041,102 | $151.7M | 0.00% | +67,444+1.0% | Added |
| Vanguard Group Inc | 5,864,781 | $126.4M | 0.00% | +258,499+4.6% | Added |
| Gendell Jeffrey L | 4,769,357 | $102.8M | 1.79% | −545,453−10.3% | Reduced |
| Weiss Asset Management LP | 4,515,114 | $97.3M | 1.38% | +4,515,114 | New |
| TIG Advisors, LLC | 3,859,122 | $83.2M | 4.01% | +3,859,122 | New |
| Tudor Investment Corp Et Al | 2,983,541 | $64.3M | 0.35% | +2,939,779+6,717.7% | Added |
| FIL Ltd | 2,822,777 | $60.8M | 0.05% | +2,822,777 | New |
| Vivo Capital, LLC | 2,684,109 | $57.8M | 3.74% | 00.0% | Unchanged |
| State Street Corp | 2,278,301 | $49.1M | 0.00% | −14,306−0.6% | Reduced |
| Geode Capital Management, LLC | 2,156,356 | $46.5M | 0.00% | −19,421−0.9% | Reduced |